Ophthalmic Business News

TAMPA, Fla. — In this Healio Video Perspective from the Telling It Like It Is meeting, P. Dee Stephenson, MD, gives an overview of promising options available for presbyopia correction.

KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2023, Kamran Hosseini, MD, PhD, CEO of Surface Ophthalmics, discusses the company’s programs for its dry eye products.

TAMPA, Florida — At the Telling It Like It Is meeting here, John W. Kitchens, MD, shared factors to consider when adding a retina specialist to an ASC.

Hosts Jim Mazzo and John A. Hovanesian, MD, FACS, chat with Richard L. Lindstrom, MD, about the latest news and trends, as well as his career and his advice for residents and entrepreneurs in the field of ophthalmology.

The FDA granted priority review for a new drug application for avacincaptad pegol for the treatment of geographic atrophy secondary to age-related macular degeneration, according to an Iveric Bio press release.

No need for an alarm clock on Feb. 15, at least in my house. My phone started blowing up around 0600 with the news: The prodigal son is back. Brent Saunders has returned to run Bausch + Lomb.

Brent Saunders has been appointed as CEO and chair of the board of directors at Bausch + Lomb, effective March 6, according to a company press release.

The FDA approved Eylea for the treatment of retinopathy of prematurity in preterm infants, according to a press release from Regeneron.

Alcon has entered into a settlement agreement with J&J Surgical Vision to resolve legal proceedings related to femtosecond laser-assisted cataract surgery devices, according to a company press release.

The FDA accepted a new drug application for Nyxol for the reversal of pharmacologically induced mydriasis, according to a press release from Ocuphire Pharma.